[Pharmacologic treatment of mild proliferation of prostatic cancer].

Abstract

In the paper, pathophysiological and clinical foundations of modern conservative therapy of mild proliferation of prostatic cancer are discussed in a short outline. The problems of treatment with hormonal and non-hormonal preparations are presented against the background of the mechanism of action of pharmacological preparations. The drugs, their dosage, effectiveness and also side effects are discussed. The importance is stressed of the drugs blocking the alpha-1 adrenergic receptors in the treatment of mild proliferation of prostatic cancer with additional beneficial mechanisms of action for the organism.

• Authors: S Dutkiewicz
• Journal: Polski tygodnik lekarski (Warsaw, Poland : 1960) (Pol Tyg Lek) Vol. 51 Issue 6-9 Pg. 67-72 (Feb 1996) ISSN: 0032-3756 [Print] Poland
• Vernacular Title: Leczenie farmakologiczne łagodnego rozrostu gruczołu krokowego.
• PMID: 8756733 (Publication Type: Editorial, English Abstract)

Chemical References

• Adrenergic alpha-Antagonists
• Anticholesteremic Agents
• Antineoplastic Agents, Hormonal

Topics

• Adrenergic alpha-Antagonists (therapeutic use)
• Anticholesteremic Agents (therapeutic use)
• Antineoplastic Agents, Hormonal (therapeutic use)
• Cell Division (drug effects)
• Humans
• Male
• Prostatic Neoplasms (drug therapy, pathology)